AGREEMENTAgreement • March 16th, 2017 • Agenus Inc • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT made and entered into in Lexington, MA, by and between Agenus Inc. (the “Company”), a Delaware corporation with a principal place of business at 3 Forbes Rd. Lexington, MA 02421, and Jean-Marie Cuillerot, MD (the “Executive”), effective as of this 10th day of March, 2017 (the “Effective Date”) (the “Agreement”). Words or phrases which are initially capitalized or are within quotation marks shall have the meanings provided in Section 14 below and as provided elsewhere herein.
AMENDMENT TO NOTES AND WARRANTSNotes and Warrants • March 16th, 2017 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This Amendment to Notes and Warrants (this “Amendment”) is entered into this 15th day of March, 2017 by and between (a) Agenus Inc., a Delaware corporation, having an address at 3 Forbes Road, Lexington, MA 02421 (the “Company”), and (b) Mark Berg, Nicole Berg, Alice Saraydarian and Khajak Keledjian (collectively, the “Original Investors”) and (c) Nicky V LLC and MSB Research Inc. (together, the “Additional Investors” and collectively with the Original Investors, the “Investors”).
